Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds RSS Feed PharmiWeb Candidate Blog RSS Feed PharmiWeb Client Blog


Press Release

Ivars Godmanis and Geliia Gildeyeva Are the New Council Members but Martins Tambaks and Mihails Raizbergs New Board Members of Olainfarm

Posted on: 23 Aug 16

Olaine, 2016-08-22 07:39 CEST (GLOBE NEWSWIRE) -- Extraordinary meeting of shareholders of AS Olainfarm held on August 16, 2016 elected a new Council of the company for a period of five years. Ivars Godmanis and Geliia Gildeyeva became the new Council members, but Aleksandrs Raicis, Gunta Veismane and Valentina Andrejeva got re-elected.  The meeting also decided to amend company’s Articles and extend the composition of the Board to seven members. Currently members of Olainfarm’s Board are Valerijs Maligins, Jelena Borcova, Olegs Grigorjevs, Veranika Dubitskaya and Salvis Lapins.


Since 2014 Mr. Godmanis has been Assistant Professor at RISEBA University and a lecturer at University of Latvia and Business University Turiba.  His previous positions include Member of European Parliament, Prime Minister of Latvia, Minister of Finance of Latvia, Minister of Interior of Latvia, Member of the Management Board of Latvijas Kugnieciba, President of Latvijas Krajbanka and Chairman of Latvian Council of Ministers.  I. Godmanis has graduated Department of Physics and Mathematics of University of Latvia, speciality of Solid Matter Physics and has a respective PhD.  Mr. Godmanis does not own any shares in AS Olainfarm.


Geliia Gildeyeva is an Assistant Professor in Department of Organization and Management of Circulation of Medicines in Moscow Medical Academy. She is also an Executive Director of Russian OOO Lekar, Member of the Council in Russian Association “National Pharmaceutical Chamber” and a leading partner in Russian OOO Medical Development Agency.  She has graduated Moscow Medical Academy, specialized in Pharmaceuticals, taken postgraduate courses in Clinical Pharmacology; she has a PhD in Biology.  Mrs Gildeyeva owns 65 916 shares in AS Olainfarm.


Martins Tambaks is a CFO of AS Olainfarm with more than 15 years of experience in finance and accounting. Mr. Tambaks joined Olainfarm in 2013, leaving his previous position in SIA “Ernst & Young Baltic”, where he was an Outsourcing Director.  Mr. Tambaks is a member of ACCA since 2006, has a Master’s degree in Economics and Accounting from Riga Technical University and University of Latvia.  Mr. Tambaks own no shares in AS Olainfarm.


Mihails Raizbergs is a CIO of AS Olainfarm with more than 17 years of experience in information and communications technologies. M. Raizbergs joined AS Olainfarm in 2006, leaving his previous position in AS Rigas Vagonbuves rupnica.  Mihails Raizbergs has a Master’s degree in Engineering from Institute of Transport and Communications; he has also graduated British Open University with professional qualifications in management. He owns 200 shares in AS Olainfarm”.




 JSC Olainfarm is one of the biggest pharmaceutical companies in Latvia with more than 40 years of experience in production of medication and chemical and pharmaceutical products. A basic principle of company's operations is to produce reliable and effective top quality products for Latvia and the rest of the world. Products made by the Group are being exported to more than 35 countries of the world, including the Baltics, Russia, other CIS, Europe, Asia, North America and Australia.

         Information prepared by:
         Salvis Lapins
         JSC Olainfarm
         Member of the Management Board
         Rupnicu iela 5, Olaine, Latvia, LV 2114
         Phone: +371 6 7013 717
         Fax: +371 6 7013 777


Last updated on: 23/08/2016

Share | | |
Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.